nach oben

Pituitary

Erschienen in:

01.08.2017

Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature

verfasst von: Elizabeth Ogando-Rivas, Andrew F. Alalade, Jerome Boatey, Theodore H. Schwartz

Erschienen in: Pituitary | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Double adenomas in the pituitary gland are a rare occurrence. The ability to cure a hormone-producing adenoma with surgery is dependent on the ability to identify and completely remove the correct adenoma. The relative frequency of each subtype of hormone-secreting adenomas confirmed with magnetic resonance image (MRI), surgery and immunohistochemistry is not defined.

Methods

Following PRISMA guidelines, we performed a systematic review of PubMed Central, Google Scholar, Scopus Database, Cochrane database and Science Research, using the key-words: “double pituitary adenomas”, “multiple pituitary adenomas” and only papers where multiple or truly separate double pituitary adenomas were identified pre-surgically by MRI and/or confirmed by pathology/immunohistochemistry staining were included.

Results

We reviewed papers from 1975 to 2016 and found 17 cases with two pituitary adenomas and 1 with three pituitary adenomas. The ages ranged from 22 to 67 years old, and there were twelve females and five males. Immunohistochemical staining showed that the most common double pituitary adenomas were growth hormone (GH)- followed by adrenocorticotropic (ACTH)-secreting.

Conclusion

Double pituitary adenomas are rare but most commonly found with GH- or ACTH-producing tumors. It is critical to remove all identified possible adenomas to achieve biochemical cure and clinicians should have heightened sensitivity in patients with acromegaly or Cushing’s Disease.

Andrioli M, Giraldi FP, Losa M, Terreni M, Invitti C, Cavagnini F (2010) Cushing’s disease due to double pituitary ACTH-secreting adenomas: the first case report. Endocr J 57(9):833–837CrossRefPubMed

Bader LJ, Carter KD, Latchaw RE, Ellis WG, Wexler JA, Watson JC (2004) Simultaneous symptomatic Rathke’s cleft cyst and GH secreting pituitary adenoma: a case report. Pituitary 7(1):3–44CrossRef

Budan RM, Georgescu CE (2016) Multiple pituitary adenomas: a systematic review. Front Endocrinol 7:1. doi:10.3389/fendo.2016.00001 CrossRef

Cannavò S, Curtò L, Lania A, Saccomanno K, Salpietro FM, Trimarchi F (1999) Unusual MRI finding of multiple adenomas in the pituitary gland: a case report and review of the literature. Magn Reson Imaging 17:633–636CrossRefPubMed

Chohan MO, Levin AM, Singh R, Zhou Z, Green CL, Kazam JJ, Tsiouris AJ, Anand VK, Schwartz TH (2016) Two-dimensional planar measurements versus three-dimensional volumetric measurements in defining giant adenoma surgery outcomes. J Neurol Surg Part B 77(S 01):A121

Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncology 3(3):152–158CrossRefPubMedPubMedCentral

de Oliveira Andrade LJ, Santos França L, Santos França L, Cordeiro de Almeida MA (2010) Double pituitary prolactinoma. J Clin Endocrinol Metab 95(11):4848–4849CrossRefPubMed

Eytan S, Kim KY, Bleich D, Raghuwanshi M, Eloy JA, Liu JK (2015) Isolated double pituitary adenomas: a silent corticotroph adenoma and a microprolactinoma. J Clin Neurosci 22(10):1676–1678CrossRefPubMed

Fliers E, Korbonits M, Romijn JA (2014) Nonfunctioning pituitary tumors. Clin Neuroendocrinol 28:167

10.

Goldberg AS, Stein R, Merritt NH, Inculet R, Van Uum S (2014) A pediatric patient with Cushing syndrome caused by ectopic ACTH syndrome and concomitant pituitary incidentalomas. J Pediatr Endocrinol Metab 27(1–2):123–128PubMed

11.

Hashimoto N, Handa H, Yamagami T, Kojima M, Aoki M, Okamoto S, Kato Y, Imura H (1984) Acromegaly with multiple secreting pituitary adenomas. Surg Neurol 22(6):556–558CrossRefPubMed

12.

Hofstetter C, Mannah RM, Mubita L, Anand VK, Dehdashti A, Schwartz TH (2010) Endoscopic endonasal approach for growth-hormone secreting pituitary adenomas. Neurosurg Focus 29(4):E6CrossRefPubMed

13.

Hofstetter C, Nanszko M, Mubita L, Tsiousris J, Anand V, Schwartz T (2011) Volumetric classification for giant pituitary macroadenomas predicts outcome and morbidity of endoscopic endonasal transsphenoidal surgery. Skull Base 21(S 01):A122CrossRef

14.

Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH (2011) Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus 30(4):E10CrossRefPubMed

15.

Jastania RA, Alsaad KO, Al-Shraim M, Kovacs K, Asa SL (2005) Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation. Endocr Pathol 16(3):187–194CrossRefPubMed

16.

Kannan S, Staugaitis SM, Weil RJ, Hatipoglu B (2012) A rare corticotroph-secreting tumor with coexisting prolactin and growth hormone staining cells. Case Rep Endocrinol 2012. doi:10.1155/2012/529730

17.

Karavitaki N, Scheithauer BW, Watt J, Ansorge O, Moschopoulos M, Llaguno AV et al (2008) Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma. Pituitary 11(3):317–323CrossRefPubMed

18.

Kim K, Yamada S, Usui M, Sano T (2004) Preoperative identification of clearly separated double pituitary adenomas. Clin Endocrinol 61(1):26–30CrossRef

19.

Kobayashi Y, Takei M, Ohkubo Y, Kakizawa Y, Matoba H, Kumagai M, Takeda T, Suzuki S, Komatsu M (2014) A somatotropin-producing pituitary adenoma with an isolated adrenocorticotropin-producing pituitary adenoma in a female patient with acromegaly, subclinical Cushing’s disease and a left adrenal tumor. Endocr J 61(6):589–595CrossRefPubMed

20.

Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH (2012) Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary 15(2):150–159CrossRefPubMed

21.

Kontogeorgos G, Scheithauer BW, Kovacs K, Lloyd RV, Smyth HS, Rologis D (1992) Double adenomas of the pituitary: a clinicopathological study of 11 tumors. Neurosurgery 31(5):840–853CrossRefPubMed

22.

Koutourousiou M, Kontogeorgos G, Wesseling P, Grotenhuis AJ, Seretis A (2010) Collision sellar lesions: experience with eight cases and review of the literature. Pituitary 13(1):8–17CrossRefPubMed

23.

Kumar KH, Prusty P (2013) Resistant prolactinoma: is it monoclonal or polyclonal?. Indian J Endocrinol Metab 17(Suppl1):S139CrossRefPubMedPubMedCentral

24.

Magri F, Villa C, Locatelli D, Scagnelli P, Lagonigro MS, Morbini P, Castellano M, Gabellieri E, Rotondi M, Solcia E, Daly AF (2010) Prevalence of double pituitary adenomas in a surgical series: clinical, histological and genetic features. J Endocrinol Investig 33(5):325–331CrossRef

25.

McKelvie PA, McNeill P (2002) Double pituitary adenomas: a series of three patients. Pathology 34(1):57–60CrossRefPubMed

26.

Mehta GU, Montgomery BK, Raghavan P, Sharma S, Nieman LK, Patronas N, Oldfield EH, Chittiboina P (2015) Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing’s disease. J Clin Neurosci 22(5):891–894CrossRefPubMedPubMedCentral

27.

Meij BP, Lopes MB, Vance ML, Thorner MO, Laws ER (2000) Double pituitary lesions in three patients with Cushing’s disease. Pituitary 3(3):159–168CrossRefPubMed

28.

Molitch ME (2008) Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 37(1):151–171CrossRefPubMed

29.

Molitch ME (2009) Pituitary tumors: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23(5):667–675CrossRefPubMed

30.

Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S, Anand VK, Schwartz TH (2016) Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas. J Neurosurg. doi:10.3171/2016.8.JNS152709

31.

Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-Oncology. 15(suppl_2):ii1–56

32.

Pantelia E, Kontogeorgos G, Piaditis G, Rologis D (1998) Triple pituitary adenoma in Cushing’s disease: case report. Acta Neurochir 140(2):190–193CrossRefPubMed

33.

Ratliff JK, Oldfield EH (2000) Multiple pituitary adenomas in Cushing’s disease. J Neurosurg 93(5):753–761CrossRefPubMed

34.

Roberts S, Borges MT, Lillehei KO, Kleinschmidt-DeMasters BK (2016) Double separate versus contiguous pituitary adenomas: MRI features and endocrinological follow up. Pituitary 19(5):472–481CrossRefPubMed

35.

Salpietro FM, Alafaci C, Grasso G, Lucerna S, Passalacqua M, Tomasello F (1999) Transsphenoidal microsurgical selective removal of multiple (triple) adenomas of the pituitary gland. Acta Neurochir 141(4):425–428CrossRefPubMed

36.

Sano T, Horiguchi H, Xu B, Li C, Hino A, Sakaki M, Kannuki S, Yamada S (1999) Double pituitary adenomas: six surgical cases. Pituitary 1(3):243–250CrossRefPubMed

37.

Shimizu C, Koike T, Sawamura Y (2004) Double pituitary adenomas with distinct histological features and immunophenotypes. J Neurol Neurosurg Psychiatry 75(1):140PubMedPubMedCentral

38.

Singh H, Essayed WI, Cohen-Gadol A, Zada G, Schwartz TH (2016) Resection of pituitary tumors: endoscopic versus microscopic. J Neuro-Oncol 130(2):309–317CrossRef

39.

Stobo DB, Lindsay RS, Connell JM, Dunn L, Forbes KP (2011) Initial experience of 3 T versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours. Clin Endocrinol 75(5):673–677CrossRef

40.

Tabaee A, Anand VK, Barrón Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111(3):545–554CrossRefPubMed

41.

Tabaee A, Anand VK, Barrón Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Predictors of short-term outcomes following endoscopic pituitary surgery. Clin Neurol Neurosurg 111(2):119–122CrossRefPubMed

42.

Tabarin A, Laurent F, Catargi B, Olivier-Puel F, Lescene R, Berge J, San Galli F, Drouillard J, Roger P, Guerin J (1998) Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing’s disease. Clin Endocrinol 49(3):293–300CrossRef

43.

Tosaka M, Kohga H, Kobayashi S, Zama A, Tamura M, Murakami M, Sasaki T (2000) Double pituitary adenomas detected on preoperative magnetic resonance images: case illustration. J Neurosurg 92(2):361CrossRefPubMed

44.

Vidal S, Syro L, Horvath E, Uribe H, Kovacs K (1999) Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas. Ultrastruct Pathol 23(3):141–148CrossRefPubMed

45.

Woosley RE (1983) Multiple secreting microadenomas as a possible cause of selective transsphenoidal adenomectomy failure: case report. J Neurosurg 58(2):267–269CrossRefPubMed

46.

Zieliński G, Maksymowicz M, Podgórski J, Olszewski WT (2013) Double, synchronous pituitary adenomas causing acromegaly and Cushing’s disease. A case report and review of literature. Endocr Pathol 24(2):92–99CrossRefPubMedPubMedCentral

47.

Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Investig 112(11):1603CrossRefPubMedPubMedCentral

48.

Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82(3):818–824PubMed

49.

Oyama K, Yamada S, Hukuhara N, Hiramatsu R, Taguchi M, Yazawa M, Matsuda A, Ohmura E, Imai Y (2006) FSH-producing macroadenoma associated in a patient with Cushing’s disease. Neuro Endocrinol Lett 27(6):733–736PubMed

Titel: Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature
verfasst von: Elizabeth Ogando-Rivas
Andrew F. Alalade
Jerome Boatey
Theodore H. Schwartz
Publikationsdatum: 01.08.2017
Verlag: Springer US
Erschienen in: Pituitary / Ausgabe 6/2017
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI: https://doi.org/10.1007/s11102-017-0826-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Evidence of dysexecutive syndrome in patients with acromegaly

The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study

Vasculogenic hyperprolactinemia: severe prolactin excess in association with internal carotid artery aneurysms

Pituitary apoplexy and rivaroxaban

MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas